These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27510560)

  • 1. Prolonged drug-induced myoclonus: is it related to palonosetron?
    Chaw SH; Chan L; Lee PK; Bakar JA; Rasiah R; Foo LL
    J Anesth; 2016 Dec; 30(6):1063-1066. PubMed ID: 27510560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study.
    Moon YE; Joo J; Kim JE; Lee Y
    Br J Anaesth; 2012 Mar; 108(3):417-22. PubMed ID: 22277663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of palonosetron for the prevention of postoperative nausea and vomiting: a randomized, double-blinded, placebo-controlled trial.
    Chun HR; Jeon IS; Park SY; Lee SJ; Kang SH; Kim SI
    Br J Anaesth; 2014 Mar; 112(3):485-90. PubMed ID: 24154700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
    Singh PM; Borle A; Gouda D; Makkar JK; Arora MK; Trikha A; Sinha A; Goudra B
    J Clin Anesth; 2016 Nov; 34():459-82. PubMed ID: 27687434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palonosetron-induced migraine-type headache.
    Jain A
    Can J Anaesth; 2011 Feb; 58(2):230-1. PubMed ID: 21132477
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia.
    Kim HJ; Lee HC; Jung YS; Lee J; Min JJ; Hong DM; Choi EK; Oh S; Jeon Y
    Br J Anaesth; 2014 Mar; 112(3):460-8. PubMed ID: 24129597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of palonosetron: emerging data distinguishing it as a novel 5-HT(3) receptor antagonist for chemotherapy-induced nausea and vomiting.
    Saito M; Tsukuda M
    Expert Opin Pharmacother; 2010 Apr; 11(6):1003-14. PubMed ID: 20307224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist.
    Navari RM
    Future Oncol; 2006 Oct; 2(5):591-602. PubMed ID: 17026451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron.
    Eisenberg P; Figueroa-Vadillo J; Zamora R; Charu V; Hajdenberg J; Cartmell A; Macciocchi A; Grunberg S;
    Cancer; 2003 Dec; 98(11):2473-82. PubMed ID: 14635083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, double-blind, multicenter trial to evaluate the therapeutic efficacy and safety of palonosetron in the treatment of postoperative nausea and vomiting over a 72-h period.
    Hahm TS; Hwang JW; Kim WH; Oh EJ; Kim DK; Choi WJ; Kim YH; Ryu JH; Yoo BH; Yon JH
    J Anesth; 2015 Feb; 29(1):21-8. PubMed ID: 25037960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
    Jin Y; Sun W; Gu D; Yang J; Xu Z; Chen J
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):41-50. PubMed ID: 22519361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.
    Gao HF; Liang Y; Zhou NN; Zhang DS; Wu HY
    Intern Med J; 2013 Jan; 43(1):73-6. PubMed ID: 22141732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Meta-Analysis of Palonosetron for the Prevention of Postoperative Nausea and Vomiting in Adults.
    Li Y; Wei X; Zhang S; Zhou L; Zhang J
    J Perianesth Nurs; 2015 Oct; 30(5):398-405. PubMed ID: 26408514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palonosetron (Aloxi) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy.
    Musso M; Scalone R; Bonanno V; Crescimanno A; Polizzi V; Porretto F; Bianchini C; Perrone T
    Support Care Cancer; 2009 Feb; 17(2):205-9. PubMed ID: 18839220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of palonosetron versus ramosetron on preventing opioid-based analgesia-related nausea and vomiting after lumbar spinal surgery: a prospective, randomized, and double-blind trial.
    Roh GU; Yang SY; Shim JK; Kwak YL
    Spine (Phila Pa 1976); 2014 Apr; 39(9):E543-9. PubMed ID: 24480956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of palonosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis.
    Xiong C; Liu G; Ma R; Xue J; Wu A
    Can J Anaesth; 2015 Dec; 62(12):1268-78. PubMed ID: 26296300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting.
    Candiotti KA; Kovac AL; Melson TI; Clerici G; Joo Gan T;
    Anesth Analg; 2008 Aug; 107(2):445-51. PubMed ID: 18633022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Ramosetron and Palonosetron for Preventing Nausea and Vomiting after Spinal Surgery: Association With ABCB1 Polymorphisms.
    Song JW; Shim JK; Choi SH; Soh S; Jang J; Kwak YL
    J Neurosurg Anesthesiol; 2017 Oct; 29(4):406-414. PubMed ID: 27564555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is palonosetron also effective for opioid-induced and post-discharge nausea and vomiting?
    Apfel CC; Jukar-Rao S
    Br J Anaesth; 2012 Mar; 108(3):371-3. PubMed ID: 22337957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.